Department of Molecular Pathology (C.L.B., P.D.P., R.P.G., L.D.M., V.B., G.B., F.F., F.N.), IRCCS Neuromed, Pozzilli, Italy.
Department of Angiocardioneurology (A.C., F.B., M.D.L., A.D., E.V., Maria Cotugno, R.S., S.M., S.S., S.R., C.V.), IRCCS Neuromed, Pozzilli, Italy.
Circ Res. 2023 May 26;132(11):1489-1504. doi: 10.1161/CIRCRESAHA.122.321744. Epub 2023 May 5.
Dkk3 (Dickkopf-3) is a secreted glycoprotein known for its proapoptotic and angiogenic activity. The role of Dkk3 in cardiovascular homeostasis is largely unknown. Remarkably, the gene maps within a chromosome segment linked to the hypertensive phenotype in spontaneously hypertensive rats (SHR).
We used Dkk3 mice or stroke-resistant (sr) and stroke-prone (sp) SHR to examine the role of Dkk3 in the central and peripheral regulation of blood pressure (BP). We used lentiviral expression vector to rescue Dkk3 in knockout mice or to induce Dkk3 overexpression or silencing in SHR.
Genetic deletion of in mice enhanced BP and impaired endothelium-dependent acetylcholine-induced relaxation of resistance arteries. These alterations were rescued by restoring Dkk3 expression either in the periphery or in the central nervous system (CNS). Dkk3 was required for the constitutive expression of VEGF (vascular endothelium growth factor), and the action of Dkk3 on BP and endothelium-dependent vasorelaxation was mediated by VEGF-stimulated phosphatidylinositol-3-kinase pathway, leading to eNOS (endothelial NO synthase) activation both in resistance arteries and the CNS. The regulatory function of Dkk3 on BP was confirmed in SHR stroke-resistant and SHR stroke-prone in which was blunted in both resistance arteries and brainstem. In SHR stroke-resistant, lentiviral expression vector-induced Dkk3 expression in the CNS largely reduced BP, whereas knock-down further enhanced BP. In SHR stroke-prone challenged with a hypersodic diet, lentiviral expression vector-induced Dkk3 expression in the CNS displayed a substantial antihypertensive effect and delayed the occurrence of stroke.
These findings demonstrate that Dkk3 acts as peripheral and central regulator of BP by promoting VEGF expression and activating a VEGF/Akt (protein kinase B)/eNOS hypotensive axis.
Dkk3(Dickkopf-3)是一种已知具有促凋亡和血管生成活性的分泌糖蛋白。Dkk3 在心血管稳态中的作用在很大程度上尚不清楚。值得注意的是,该基因位于与自发性高血压大鼠(SHR)高血压表型相关的染色体片段内。
我们使用 Dkk3 基因敲除小鼠或抗中风(sr)和易中风(sp)SHR 来研究 Dkk3 在血压(BP)的中枢和外周调节中的作用。我们使用慢病毒表达载体在敲除小鼠中恢复 Dkk3 的表达,或在 SHR 中诱导 Dkk3 的过表达或沉默。
在小鼠中, 基因的缺失增强了 BP 并损害了阻力血管内皮依赖性乙酰胆碱诱导的松弛。在外周或中枢神经系统(CNS)中恢复 Dkk3 的表达可挽救这些改变。Dkk3 是 VEGF(血管内皮生长因子)的组成型表达所必需的,Dkk3 对 BP 和内皮依赖性血管舒张的作用是通过 VEGF 刺激的磷脂酰肌醇-3-激酶途径介导的,导致 eNOS(内皮型一氧化氮合酶)在阻力血管和 CNS 中均被激活。在 SHR 抗中风和 SHR 易中风中,Dkk3 对 BP 的调节作用得到了证实,在这两种情况下,阻力血管和脑干中的作用均减弱。在 SHR 抗中风中,用慢病毒表达载体诱导 CNS 中的 Dkk3 表达在很大程度上降低了 BP,而 敲低进一步增强了 BP。在 SHR 易中风接受高盐饮食挑战时,用慢病毒表达载体诱导 CNS 中的 Dkk3 表达显示出显著的降压作用并延迟中风的发生。
这些发现表明,Dkk3 通过促进 VEGF 表达并激活 VEGF/Akt(蛋白激酶 B)/eNOS 降压轴来作为 BP 的外周和中枢调节剂。